β-内酰胺药物及β-内酰胺酶相关的研究进展  

Research progress inβ-lactam drugs andβ-lactamases

作　　者：王昊 刘聪 薛云新[1] 王岱[1] 牛建军 赵西林[1] Wang Hao;Liu Cong;Xue Yun-xin;Wang Dai;Niu Jian-jun;Zhao Xi-lin(State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics,Xiamen University,Xiamen 361102)

机构地区：[1]分子疫苗学和分子诊断学国家重点实验室,厦门大学公共卫生学院,厦门361102

出　　处：《中国抗生素杂志》2021年第4期297-304,共8页Chinese Journal of Antibiotics

基　　金：国家自然科学基金(No.81971905);福建省海洋经济发展补助资金项目(No.FJHJF-L-2019-4);福建省教育厅中青年教师教育科研项目(No.JT180009);“十三五”厦门市国家海洋经济创新发展示范项目(No.16PZY002SF18);分子疫苗学与分子诊断学国家重点实验室开放研究项目(No.SKLVD2018KF005)。

摘　　要：抗生素的发明和使用给人类战胜病原菌感染提供了有力武器,然而因为抗生素的滥用,以细菌为代表的病原体通过进化产生抗性从而抵抗抗生素的杀伤作用。作为最早出现的一类抗生素,β-内酰胺类抗生素具有杀菌活性强、毒性低、适应症广及临床疗效好的特点,得到了广泛使用。细菌可以通过表达β-内酰胺酶来抵抗β-内酰胺药物的杀伤作用。随着微生物学、化学、药学等学科交叉发展,对β-内酰胺酶进行研究,开展对其检测分型并有针对性地开发其抑制剂对于克服细菌耐药,挽救患者生命有重要意义。The invention and use of antibiotics have provided humans with a powerful weapon to defeat pathogens.However,due to abuse of antibiotics,many bacterial pathogens have evolved ways to resist the killing effects of antibiotics.As the earliest class of antibiotics,β-lactam antibiotics have been widely and successfully used for their strong bactericidal activity,low toxicity,wide indications,and good clinical effi cacy.But bacteria can resist the killing effects ofβ-lactam drugs by expressingβ-lactamase.With the interdisciplinary collaboration of microbiology,chemistry,pharmacy,a nd other specialties,studies onβ-lactamases including their detection and typing,and targeted inhibitors are of great signifi cance to overcome bacterial resistance and save patient s'lives.

关 键 词：细菌耐药 β-内酰胺药物 Β-内酰胺酶 检测 抑制剂 

分 类 号：R978.1[医药卫生—药品] Q939.92[医药卫生—药学]